Cancer Letters
Volume 230, Issue 1 , Pages 1-5, 8 December 2005

Effects of active MEK1 expression in vivo

  • Florence A. Scholl

      Affiliations

    • VA Palo Alto Healthcare System, Palo Alto, CA, USA
    • Program in Epithelial Biology, Standford University School of Medicine, Stanford, CA, USA
  • ,
  • Phillip A. Dumesic

      Affiliations

    • VA Palo Alto Healthcare System, Palo Alto, CA, USA
    • Program in Epithelial Biology, Standford University School of Medicine, Stanford, CA, USA
  • ,
  • Paul A. Khavari

      Affiliations

    • VA Palo Alto Healthcare System, Palo Alto, CA, USA
    • Program in Epithelial Biology, Standford University School of Medicine, Stanford, CA, USA
    • Corresponding Author InformationCorresponding author. Address: Program in Epithelial Biology, 269 Campus Drive, Room 2150, Standford, CA 94305, USA. Tel.: +1 650 725 5266; fax: +1 650 723 8762.

Received 7 December 2004; accepted 13 December 2004.

Abstract 

Cell transformation is often a result of constitutive activation of genes in signaling pathways that regulate cell proliferation and differentiation. Indeed, the Ras/Raf/MEK/ERK mitogen-activated protein kinase (MAPK) signaling pathway is constitutively activated in a large number of cancers. The extent to which a single-gene mutation can alter cell fate, however, remains questionable. In vitro studies have addressed this issue, but organs are comprised of multiple cell types, and in vitro models often poorly approximate these interactions. In response to these limitations, cell-type specific mouse models have been generated as a means to examine the effect of altering a single element of the MAPK pathway in vivo. This review summarizes data from transgenic murine and human tissue models expressing constitutive active forms of MEK1.

Keywords: MEK1 expression, MAPK pathway, Oncogenic Ras

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(04)00989-9

doi:10.1016/j.canlet.2004.12.013

Cancer Letters
Volume 230, Issue 1 , Pages 1-5, 8 December 2005